|
1
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lu H, Stratton CW and Tang YW: Outbreak of
pneumonia of unknown etiology in Wuhan, China: The mystery and the
miracle. J Med Virol. 92:401–402. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Neagu M, Calina D, Docea AO, Constantin C,
Filippini T, Vinceti M, Drakoulis N, Poulas K, Nikolouzakis TK,
Spandidos DA and Tsatsakis A: Back to basics in COVID-19: Antigens
and antibodies-completing the puzzle. J Cell Mol Med. 25:4523–4533.
2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Islam MT, Quispe C, Herrera-Bravo J, Khan
IN, Bawazeer SS, Kumar M, Cruz-Martins N, Martorell M, Docea AO,
Sharifi-Rad J, et al: Possible mutation pathways in SARS-Cov-2.
Farmacia. 69:1001–1017. 2021.
|
|
5
|
Ritchie H, Mathieu E, Rodés-Guirao L,
Appel C, Giattino C, Ortiz-Ospina E, Hasell J, Macdonald B,
Beltekian D and Roser M: Coronavirus Pandemic (COVID-19), 2020.
Available from https://ourworldindata.org/coronavirus=.
|
|
6
|
Calina D, Hartung T, Mardare I, Mitroi M,
Poulas K, Tsatsakis A, Rogoveanu I and Docea AO: COVID-19 pandemic
and alcohol consumption: Impacts and interconnections. Toxicol Rep.
8:529–535. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Michelen M, Manoharan L, Elkheir N, Cheng
V, Dagens A, Hastie C, O'Hara M, Suett J, Dahmash D, Bugaeva P, et
al: Characterising long COVID: A living systematic review. BMJ Glob
Health. 6(e005427)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He
JX, Liu L, Shan H, Lei CL, Hui DSC, et al: Clinical characteristics
of coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Goumenou M, Sarigiannis D, Tsatsakis A,
Anesti O, Docea AO, Petrakis D, Tsoukalas D, Kostoff R, Rakitskii
V, Spandidos DA, et al: COVID-19 in Northern Italy: An integrative
overview of factors possibly influencing the sharp increase of the
outbreak (Review). Mol Med Rep. 22:20–32. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Popov GT, Baymakova M, Vaseva V,
Kundurzhiev T and Mutafchiyski V: Clinical characteristics of
hospitalized patients with COVID-19 in Sofia, Bulgaria. Vector
Borne Zoonotic Dis. 20:910–915. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lechien JR, Chiesa-Estomba CM, Place S,
Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S,
et al: Clinical and epidemiological characteristics of 1420
European patients with mild-to-moderate coronavirus disease 2019. J
Intern Med. 288:335–344. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Calina D, Hartung T, Docea AO, Spandidos
DA, Egorov AM, Shtilman MI, Carvalho F and Tsatsakis A: COVID-19
vaccines: Ethical framework concerning human challenge studies.
Daru. 28:807–812. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Calina D, Hernández AF, Hartung T, Egorov
AM, Izotov BN, Nikolouzakis TK, Tsatsakis A, Vlachoyiannopoulos PG
and Docea AO: Challenges and scientific prospects of the newest
generation of mRNA-based vaccines against SARS-CoV-2. Life (Basel).
11(907)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sidiropoulou P, Docea AO, Nikolaou V,
Katsarou MS, Spandidos DA, Tsatsakis A, Calina D and Drakoulis N:
Unraveling the roles of vitamin D status and melanin during
Covid-19 (Review). Int J Mol Med. 47:92–100. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Islam MT, Quispe C, Martorell M, Docea AO,
Salehi B, Calina D, Reiner Ž and Sharifi-Rad J: Dietary
supplements, vitamins and minerals as potential interventions
against viruses: Perspectives for COVID-19. Int J Vitam Nutr Res.
92:49–66. 2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pang NY, Pang AS, Chow VT and Wang DY:
Understanding neutralising antibodies against SARS-CoV-2 and their
implications in clinical practice. Mil Med Res.
8(47)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Garcia-Beltran WF, Lam EC, Astudillo MG,
Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL,
Nitido AD, et al: COVID-19-neutralizing antibodies predict disease
severity and survival. Cell. 184:476–488.e11. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Guo L, Ren L, Yang S, Xiao M, Chang D,
Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, et al: Profiling early
humoral response to diagnose novel coronavirus disease (COVID-19).
Clin Infect Dis. 71:778–785. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mazzini L, Martinuzzi D, Hyseni I,
Benincasa L, Molesti E, Casa E, Lapini G, Piu P, Trombetta CM,
Marchi S, et al: Comparative analyses of SARS-CoV-2 binding (IgG,
IgM, IgA) and neutralizing antibodies from human serum samples. J
Immunol Methods. 489(112937)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lee J, Park SS, Kim TY, Lee DG and Kim DW:
Lymphopenia as a biological predictor of outcomes in COVID-19
patients: A nationwide cohort study. Cancers (Basel).
13(471)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang R, Luo X, Liu F and Luo S:
Confronting the threat of SARS-CoV-2: Realities, challenges and
therapeutic strategies (Review). Exp Ther Med.
21(155)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ursu RG, Luca CM, Luca AS, Toader E,
Simion L and Iancu LS: Laboratory diagnosis for optimize therapy of
B hepatitis virus infection by using biochemical and molecular
biology methods. Rev Chim (Bucharest). 67:2614–2617. 2016.
|
|
24
|
Ortega MA, Fraile-Martínez O,
García-Montero C, García-Gallego S, Sánchez-Trujillo L,
Torres-Carranza D, Álvarez-Mon MÁ, Pekarek L, García-Honduvilla N,
Bujan J, et al: An integrative look at SARS-CoV-2 (Review). Int J
Mol Med. 47:415–434. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Woof JM and Kerr MA: The function of
immunoglobulin A in immunity. J Pathol. 208:270–282.
2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Dietzen DJ: Amino acids, peptides, and
proteins. In: Principles and Applications of Molecular Diagnostics.
Rifai N, Horvath AR and Wittwer CT (eds). Elsevier, Amsterdam,
pp345-380, 2018.
|
|
27
|
Stancioiu F, Papadakis GZ, Kteniadakis S,
Izotov BN, Coleman MD, Spandidos DA and Tsatsakis A: A dissection
of SARS-CoV2 with clinical implications (Review). Int J Mol Med.
46:489–508. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chvatal-Medina M, Mendez-Cortina Y, Patiño
PJ, Velilla PA and Rugeles MT: Antibody responses in COVID-19: A
review. Front Immunol. 12(633184)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sterlin D, Mathian A, Miyara M, Mohr A,
Anna F, Claër L, Quentric P, Fadlallah J, Devilliers H, Ghillani P,
et al: IgA dominates the early neutralizing antibody response to
SARS-CoV-2. Sci Transl Med. 13(eabd2223)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Meinberger D, Koch M, Roth A, Hermes G,
Stemler J, Cornely OA, Streichert T and Klatt AR: Analysis of IgM,
IgA, and IgG isotype antibodies directed against SARS-CoV-2 spike
glycoprotein and ORF8 in the course of COVID-19. Sci Rep.
11(8920)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yu HQ, Sun BQ, Fang ZF, Zhao JC, Liu XY,
Li YM, Sun XZ, Liang HF, Zhong B, Huang ZF, et al: Distinct
features of SARS-CoV-2-specific IgA response in COVID-19 patients.
Eur Respir J. 56(2001526)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Okba NMA, Müller MA, Li W, Wang C,
GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E,
Chandler FD, et al: Severe acute respiratory syndrome coronavirus
2-specific antibody responses in coronavirus disease patients.
Emerg Infect Dis. 26:1478–1488. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Carnicelli A, Fiori B, Ricci R, Piano A,
Bonadia N, Taddei E, Fantoni M, Murri R, Cingolani A, Barillaro C,
et al: Characteristic of IgA and IgG antibody response to
SARS-CoV-2 infection in an Italian referral COVID-19 hospital.
Intern Emerg Med. 17:53–64. 2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Korte W, Buljan M, Rösslein M, Wick P,
Golubov V, Jentsch J, Reut M, Peier K, Nohynek B, Fischer A, et al:
SARS-CoV-2 IgG and IgA antibody response is gender dependent; and
IgG antibodies rapidly decline early on. J Infect. 82:e11–e14.
2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ma H, Zeng W, He H, Zhao D, Jiang D, Zhou
P, Cheng L, Li Y, Ma X and Jin T: Serum IgA, IgM, and IgG responses
in COVID-19. Cell Mol Immunol. 17:773–775. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zervou FN, Louie P, Stachel A,
Zacharioudakis IM, Ortiz-Mendez Y, Thomas K and Aguero-Rosenfeld
ME: SARS-CoV-2 antibodies: IgA correlates with severity of disease
in early COVID-19 infection. J Med Virol. 93:5409–5415.
2021.PubMed/NCBI View Article : Google Scholar
|
